Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib plus irradiated allogeneic lymphocytes in metastatic renal cell carcinoma
NCT00853125Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Feb 2009
- Primary completion
- Feb 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of irradiated donor lymphocytes in renal cell carcinoma (RCC), sponsored by Rutgers University. Started Feb 2009; status: terminated.
02
Drugs
irradiated donor lymphocytes
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00853125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853125.